Howard County BOE sues drug manufacturers over surging insulin prices
The school board is responsible for purchasing insurance for all of its employees, retirees and dependents. The district has more than 7,800 educators, administrators and staff, according to the complaint.
Increases in spending have “detrimental effects” on the budget and consequently, the school board’s ability to provide services to the community, the lawsuit states.
During the past 20 years, the average cost of consumer goods and services has risen 1.75-fold while the cost of some diabetes medications has risen more than 10-fold, the complaint reads. The price increases are not caused by a rise in production costs or investments in development but by the defendants manipulating them to “exponentially increase their profits at the expense of payors.” This is all part of what the suit calls an “Insulin Pricing Scheme” by insulin manufacturers.
Health insurance plans are funded by payors such as
Pharmacy benefits managers CVS Caremark,
The defendants are the largest benefits managers in the country, owning more than 80% of the market, the lawsuit states. They are also the largest pharmacies in the
The national formularies drive drug utilization, the suit states, and the exclusion of a drug from one or more of the benefit managers’ formularies can render the drug virtually inaccessible for millions.
The complaint argues manufacturers are artificially inflating their list prices and then paying a significant, yet undisclosed, portion of that inflated price back to the PBMs through rebate aggregators. The aggregators are PBM subsidiaries and “secure additional profits from each drug purchase.”
“The PBMs intentionally work to incentivize the Manufacturers to inflate their list prices,” the complaint said. “The PBMs’ ‘negotiations’ intentionally drive up the price of the at-issue drugs and are directly responsible for the skyrocketing prices of diabetes medications, conferring unearned benefits upon the PBMs and Manufacturers alike and overcharging payors like Howard County BOE. ”
Payors like the
Pharmaceutical companies alone are responsible for the prices they set in the marketplace for the products they manufacture,
“Nothing in our agreements prevents drug manufacturers from lowering the prices of their insulin products and we would welcome such an action,” Prinzing said. ” Allegations that we play any role in determining the prices charged by manufacturers for their products are false, and we intend to vigorously defend against this baseless suit.”
Optum Rx said the lawsuit is baseless, demonstrating a “profound misunderstanding of how drug pricing works.”
“For many years, Optum Rx has aggressively and successfully negotiated with drug manufacturers and taken additional actions to lower prescription insulin costs for our health plan customers and their members, who now pay an average of less than
Eli Lilly,
Have a news tip? Contact
©2025 Baltimore Sun. Visit baltimoresun.com. Distributed by Tribune Content Agency, LLC.


Trump shares handwritten note to Powell: 'You have cost the USA A Fortune'
How Trump's tax bill could cut Medicaid for millions of Americans
Advisor News
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
More Advisor NewsAnnuity News
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity NewsHealth/Employee Benefits News
- MEDICAL FRAILTY AND MEDICAID WORK REQUIREMENTS: CHALLENGES FOR PEOPLE WITH MENTAL HEALTH CONDITIONS
- HOW NEW PHYSICIANS CAN AVOID PAYMENT PITFALLS IN MEDICARE AND MEDICAID
- WHITEHOUSE, WYDEN, OSSOFF DEMAND BIG HEALTH INSURANCE CEOS DELIVER ON PROMISES TO REDUCE PATIENT CARE DELAYS
- Medicaid work rules don’t apply to Native Americans. They could still lose coverage.
- Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
More Health/Employee Benefits NewsLife Insurance News
- Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
- Military Briefs: November 19-25
- California’s new solvency rules: What should life insurance advisors watch?
- Navigating delayed death certificates: A guide for life insurance advisors
- Jackson Launches Direct-to-Consumer Annuity Offering
More Life Insurance News